International Stem Cell Corporation , a California-based biotechnology company developing novel stem cell based therapies and biomedical products, today announced that Executive Vice President Dr. Simon Craw, will present a corporate overview of ISCO and its subsidiaries at the 26th Annual ROTH Conference on Monday, March 10th at 3:30 p.m. PDT.
http://ift.tt/1kptNez
http://ift.tt/1kptNez
No comments:
Post a Comment